Hubbard Dallin, Enda Michael, Bond Tanner, Moghaddam Seyyed Pouya Hadipour, Conarton Josh, Scaife Courtney, Volckmann Eric, Ghandehari Hamidreza
Utah Center for Nanomedicine, Nano Institute of Utah, University of Utah , 36 South Wasatch Drive, Salt Lake City, Utah 84112, United States.
Department of Bioengineering, University of Utah , 36 South Wasatch Drive, Salt Lake City, Utah 84112, United States.
Mol Pharm. 2015 Nov 2;12(11):4099-107. doi: 10.1021/acs.molpharmaceut.5b00541. Epub 2015 Oct 12.
Poly(amido amine) (PAMAM) dendrimers have shown transepithelial transport across intestinal epithelial barrier in rats and across Caco-2 cell monolayers. Caco-2 models innately lack mucous barriers, and rat isolated intestinal tissue has been shown to overestimate human permeability. This study is the first report of transport of PAMAM dendrimers across isolated human intestinal epithelium. It was observed that FITC labeled G4-NH2 and G3.5-COOH PAMAM dendrimers at 1 mM concentration do not have a statistically higher permeability compared to free FITC controls in isolated human jejunum and colonic tissues. Mannitol permeability was increased at 10 mM concentrations of G3.5-COOH and G4-NH2 dendrimers. Significant histological changes in human colonic and jejunal tissues were observed at G3.5-COOH and G4-NH2 concentrations of 10 mM implying that dose limiting toxicity may occur at similar concentrations in vivo. The permeability through human isolated intestinal tissue in this study was compared to previous rat and Caco-2 permeability data. This study implicates that PAMAM dendrimer oral drug delivery may be feasible, but it may be limited to highly potent drugs.
聚(酰胺胺)(PAMAM)树枝状大分子已显示出可通过大鼠肠道上皮屏障进行跨上皮转运,并可穿过Caco-2细胞单层。Caco-2模型天生缺乏黏液屏障,并且已证明大鼠离体肠道组织会高估人体通透性。本研究是关于PAMAM树枝状大分子跨离体人肠上皮转运的首次报道。据观察,在离体人空肠和结肠组织中,1 mM浓度的异硫氰酸荧光素(FITC)标记的G4-NH2和G3.5-COOH PAMAM树枝状大分子与游离FITC对照相比没有统计学上更高的通透性。在10 mM浓度的G3.5-COOH和G4-NH2树枝状大分子作用下,甘露醇通透性增加。在10 mM的G3.5-COOH和G4-NH2浓度下,观察到人体结肠和空肠组织有明显的组织学变化,这意味着在体内相似浓度下可能会出现剂量限制性毒性。本研究中通过人体离体肠道组织的通透性与先前大鼠和Caco-2的通透性数据进行了比较。本研究表明,PAMAM树枝状大分子口服给药可能是可行的,但可能仅限于高效能药物。